Promis Neurosciences Share Price Today (NASDAQ: PMN)

Name: Promis Neurosciences Share Price (NASDAQ: PMN) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Promis Neurosciences share price is 0.48 & ₹41.11 as on 17 May 2025, 2.30 'hrs' IST

$0.48

▲

-0.05

(-9.43%)

Market is closed - opens 7 PM, 19 May 2025

View live Promis Neurosciences share price in Dollar and Rupees. Guide to invest in Promis Neurosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Promis Neurosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Promis Neurosciences share price movements

Today's Low: $0.48
Today's High: $0.51
$0.48
0.0%
Downside
Day's Volatility :5.88%
Upside
5.88%
52 Weeks Low: $0.47
52 Weeks High: $2.37
$0.48
2.04%
Downside
52 Weeks Volatility :80.16%
Upside
79.75%

Promis Neurosciences (PMN) Returns

Period	Promis Neurosciences Inc	Index (Russel 2000)
3 Months	-46.67%	0.0%
6 Months	-52.94%	0.0%
1 Year	-73.98%	0.0%
3 Years	-94.81%	-0.3%

Promis Neurosciences (PMN) Key Statistics

in dollars & INR

Previous Close	$0.53
Open	$0.51
Today's High	$0.51
Today's Low	$0.48
Market Capitalization	$17.3M
Today's Volume	$38.5K
52 Week High	$2.37
52 Week Low	$0.4702
Revenue TTM	$7.6K
EBITDA	$-13.3M
Earnings Per Share (EPS)	$0.11
PE Ratio	4.82
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	27.46%

How to invest in Promis Neurosciences Stock (PMN) from India?

It is very easy for Indian residents to invest directly in Promis Neurosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Promis Neurosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Promis Neurosciences or PMN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Promis Neurosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Promis Neurosciences shares which would translate to 1.784 fractional shares of Promis Neurosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Promis Neurosciences, in just a few clicks!

Returns in Promis Neurosciences (PMN) for Indian investors in Rupees

The Promis Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Promis Neurosciences investment value today

Current value as on today

₹28,818

Returns

₹71,182

(-71.18%)

Returns from Promis Neurosciences Stock

₹73,913 (-73.91%)

Dollar Returns

₹2,731 (+2.73%)

Indian investors sentiment towards Promis Neurosciences (PMN)

-50%

Period: Apr 17, 2025 to May 17, 2025. Change in 30 Days versus previous period

Search interest for Promis Neurosciences Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Promis Neurosciences

Great Point Partners LLC
8.09%
Armistice Capital, LLC
7.68%
Sphera Funds Management Ltd.
5.90%
Ally Bridge Group (NY) LLC
4.87%
Altium Capital Management, LP
1.78%
Allostery Investments LP
0.60%

Analyst Recommendation on Promis Neurosciences

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Promis Neurosciences(by analysts ranked 0 to 5 stars)

Analyst Forecast on Promis Neurosciences Stock (PMN)

What analysts predicted

Upside of 1086.4%

Target:

$5.69

Current:

$0.48

Insights on Promis Neurosciences Stock (Ticker Symbol: PMN)

Price Movement
In the last 1 month, PMN stock has moved down by -24.4%
PMN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 90.9% return, outperforming this stock by 164.9%
Price to Sales
ForPMN every $1 of sales, investors are willing to pay $480.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.6 for every $1 of sales.

Promis Neurosciences Technicals Summary

Sell

Neutral

Buy

Promis Neurosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Promis Neurosciences (PMN) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Promis Neurosciences Inc	-15.34%	-52.94%	-73.98%	-94.81%	-94.81%
Regeneron Pharmaceuticals, Inc.	5.81%	-22.03%	-39.82%	-9.59%	6.55%
Vertex Pharmaceuticals Incorporated	-8.14%	-6.07%	-1.62%	71.71%	55.39%
Alnylam Pharmaceuticals, Inc.	22.5%	22.76%	89.78%	120.42%	100.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Promis Neurosciences Inc	4.82	4.82	NA	0.0	0.27	-0.51	NA	0.5
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.26	35.5	0.16	0.07	0.01	277.5
Vertex Pharmaceuticals Incorporated	32.84	NA	2.59	18.0	-0.06	0.12	NA	64.2
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.06	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Promis Neurosciences Inc	Buy	$17.3M	-94.81%	4.82	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$63.2B	6.55%	14.86	31.94%
Vertex Pharmaceuticals Incorporated	Buy	$111.5B	55.39%	32.84	-8.91%
Alnylam Pharmaceuticals, Inc.	Buy	$34.9B	100.22%	NA	-11.49%

About Promis Neurosciences

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's Disease; PMN267 for treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.

Organization	Promis Neurosciences
Employees	7
CEO	Mr. Neil K. Warma M.B.A.
Industry	Miscellaneous

Management People of Promis Neurosciences

Name	Title
Mr. Eugene W. Williams	Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.	CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.	Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Mr. Daniel E. Geffken M.B.A.	Chief Financial Officer
Dr. Johanne Kaplan Ph.D.	Chief Development Officer
Dr. David Wishart Ph.D.	Chief Physics Officer
Mr. Dennis Chen Ph.D.	Head of Manufacturing & Senior Consultant
Dr. Larry Douglas Altstiel M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in PMN Stock from India :

Can Indians buy Promis Neurosciences shares?

Yes, Indians can invest in the Promis Neurosciences (PMN) from India.

With INDmoney, you can buy Promis Neurosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Promis Neurosciences at zero transaction cost.

How can I buy Promis Neurosciences shares from India?

It is very easy to buy Promis Neurosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Promis Neurosciences (PMN) be purchased?

Yes, you can buy fractional shares of Promis Neurosciences with INDmoney app.

What are the documents required to start investing in Promis Neurosciences stocks?

To start investing in Promis Neurosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Promis Neurosciences share price today?

Promis Neurosciences share price today stands at $0.48, Open: $0.51 ; Previous Close: $0.53 ; High: $0.51 ; Low: $0.48 ; 52 Week High: $2.37 ; 52 Week Low: $0.47.

The stock opens at $0.51, after a previous close of $0.53. The stock reached a daily high of $0.51 and a low of $0.48, with a 52-week high of $2.37 and a 52-week low of $0.47.